Ubs Group Ag Cytek Biosciences, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 18,944 shares of CTKB stock, worth $124,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,944

Previous 79,532 76.18%

Holding current value

$124,083

Previous $443,000 76.52%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.73 - $6.73 $286,581 - $407,757	-60,588 Reduced 76.18%	18,944 $104,000
Q2 2024 Aug 13, 2024	SELL	$5.3 - $6.91 $17,887 - $23,321	-3,375 Reduced 4.07%	79,532 $443,000
Q1 2024 May 13, 2024	BUY	$6.29 - $9.15 $521,346 - $758,397	82,885 Added 376750.0%	82,907 $556,000
Q4 2023 Feb 09, 2024	SELL	$4.1 - $9.51 $2,439 - $5,658	-595 Reduced 96.43%	22 $0
Q3 2023 Nov 09, 2023	SELL	$5.52 - $9.5 $1.28 Million - $2.2 Million	-231,992 Reduced 99.73%	617 $3,000
Q2 2023 Aug 11, 2023	BUY	$6.69 - $11.99 $1.04 Million - $1.86 Million	155,295 Added 200.86%	232,609 $1.99 Million
Q1 2023 May 12, 2023	BUY	$8.44 - $13.47 $271,751 - $433,707	32,198 Added 71.37%	77,314 $710,000
Q4 2022 Feb 08, 2023	BUY	$9.71 - $15.86 $399,110 - $651,893	41,103 Added 1024.25%	45,116 $460,000
Q3 2022 Nov 10, 2022	BUY	$10.96 - $15.45 $43,292 - $61,027	3,950 Added 6269.84%	4,013 $59,000
Q2 2022 Aug 10, 2022	BUY	$7.41 - $11.56 $466 - $728	63 New	63 $1,000
Q4 2021 Feb 14, 2022	SELL	$16.14 - $25.04 $13,412 - $20,808	-831 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.52 - $27.93 $14,559 - $23,209	831 New	831 $18,000

Others Institutions Holding CTKB

# of Institutions

135

Shares Held

72.2M

Call Options Held

400

Put Options Held

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $882M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account